« I think this is the first time it has happened in the history of cancer. Dr. Luis A. Diaz Jr. of the Sloan Kettering Cancer Center Memorial is still recovering. Along with other doctors, he published an article in the New England Journal of Medicine proposing a clinical trial for 18 patients with colorectal cancer.
For six months, these 18 patients received a dose of dostarlimab every three weeks. What a doctor, at $ 11,000 a dose, ” unmasks cancer cells, allowing the immune system to identify and destroy them He explains New York Times.
The cancer is gone
The results described are astonishing: these 18 patients appear to have been completely cured. No more traces of cancer are detectable on examination, including MRI. « This is unprecedented Dr. Alan P. Venook, a colorectal cancer specialist at the University of California, San Francisco, told the New York Times. Cherry on the cake: No significant side effects were observed.
Although it is unknown at this time whether patients are permanently cured (can cancer return?), All specialists interviewed call for this trial to be replicated.
A drug that exists in France
Le dostarlimab is known in France as Jemperli. It is indicated for the treatment of adult patients with endometrial cancer, recurrent or advanced. In October 2021, the High Health Authority issued an unfavorable opinion on its Social Security reimbursement.
The health authorities then put forward ” the lack of robust comparative data “,” the very preliminary nature of the available efficacy data », Or bis« a higher risk premium for drugs whose efficacy is well-founded ».
War in Ukraine: Russia allegedly detained nearly 600 people in the Kherson region
The only smartphone charger will be introduced in Europe in 2024
Marc Dutroux: In Marcinelle, Belgium, the demolition of his house has begun
Continue reading on this topic (s):